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Solution Structure of the MAPK Phosphatase PAC-1
Catalytic Domain: Insights into Substrate-Induced
Enzymatic Activation of MKP
ability to recognize distinctively different dual-phos-
phorylation sites containing the pT-X-pY motif, where
pT and pY are phosphothreonine and phosphotyrosine
and X is glutamate, proline, or glycine, respectively, in
the three different classes of MAPKs.
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Mount Sinai School of Medicine Recent studies have shown that direct binding of the
N-terminal kinase binding domains to selective MAPKsNew York University
One Gustave L. Levy Place also contributes to the substrate specificity of MKPs
[15–19]. More strikingly, this direct enzyme-substrateNew York, New York 10029
interaction results in catalytic activation of MKP-3 [16],
which otherwise exhibits very low phosphatase activity
in the absence of substrates. Structural and biochemicalSummary
studies of MKP-3 have further demonstrated that the
enzyme utilizes a conserved XXRRXXKXXLXV motif inInactivation of mitogen-activated protein kinases
its N-terminal kinase binding domain for specific interac-(MAPKs) by MAPK phosphatases (MKPs) is accom-
tion with ERK2 [20–23] and that MKP-3 activity is con-plished via substrate-induced activation of the latter
trolled by a mechanism of substrate-induced activation,enzymes; however, the structural basis for the under-
rather than autoinhibition [20, 24, 25]. The latter mecha-lying mechanism remains elusive. Here, we report the
nism is seen in the SHP-2 tyrosine phosphatase [26].three-dimensional solution structure of the C-terminal
Collectively, these studies suggest that MKP-3 bindingphosphatase domain of the prototypical MKP PAC-1,
to ERK2 allosterically causes conformational rearrange-determined when bound to phosphate. Structural and
ment of the C-terminal phosphatase domain, leading tobiochemical analyses reveal unique active site geome-
its catalytic activation [16, 20]. This hypothesis seemstry of the enzyme important for binding to phosphory-
consistent with the three-dimensional crystal structurelated threonine and tyrosine of MAPK ERK2. Our study
of the free MKP-3 phosphatase domain, which showsfurther demonstrates that the dynamic interaction be-
that the key catalytic residues at the active site aretween the N-terminal kinase binding domain and the
structurally disengaged for catalysis [27].C-terminal phosphatase domain of an MKP is directly
Despite these important advances, major questionscoupled to MAPK-induced conformational change of
regarding the structural basis of substrate recognitionthe phosphatase active site, which is essential for elic-
and the mechanism of substrate-induced catalytic acti-iting its full enzymatic activity.
vation of MKPs remain unanswered. For instance, do
dual-specificity MKPs interact with phosphothreonine
Introduction and phosphotyrosine in the activation loop of an MAPK
simultaneously? What amino acid residues flanking
Mitogen-activated protein kinases (MAPKs) play a piv- phosphothreonine and phosphotyrosine in MAPKs are
otal role in controlling numerous cellular processes, in- specifically recognized by MKPs? How does an MAPK
cluding differentiation, mitogenesis, oncogenesis, and binding by an MKP affect conformational rearrangement
apoptosis [1–3]. The biological importance of MAPKs is of the phosphatase active site, which results in its cata-
underscored by tight control of their activation through lytic activation? In an effort to address these questions,
dual phosphorylation of threonine and tyrosine in the we have determined the three-dimensional solution
activation loop [1–5] and their inactivation by a family structure of the C-terminal phosphatase domain from
of dual-specificity MAPK phosphatases (MKPs), many the prototypical MKP PAC-1 using nuclear magnetic
of which are encoded by early genes induced by MAPKs, resonance (NMR) spectroscopy. We have further investi-
thus forming a negative-feedback mechanism [6, 7]. All gated the structural basis of its substrate recognition
MKPs consist of two functional domains—an N-terminal and interdomain interaction with the conserved N-ter-
kinase binding domain and a C-terminal phosphatase minal kinase binding domain. Our findings provide new
domain. Many MKPs exhibit distinct substrate specific- insights into the structural and functional relationships
ity toward three major classes of MAPKs, i.e., extracellu- of MKPs.
lar signal-regulated kinases (ERK1/2), c-Jun N-terminal
kinases/stress-activated protein kinases (JNK-1/2/3/ Results and Discussion
SAPK), and p38 proteins (p38///) [8, 9]. For instance,
PAC-1 that is expressed predominantly in hematopoietic Structure Determination
cells was discovered by virtue of its specific inactivation To conduct the NMR structural analysis, we substituted
of ERKs in T cell activation [10, 11], whereas MKP-3 and the enzymatic nucleophile C257 with serine for the
M3-6 are highly selective in inactivating ERKs or JNK/ C-terminal phosphatase domain of human PAC-1 (Fig-
SAPK and p38 MAPKs, respectively [12–14]. This high ures 1A and 1B). Mutation of the equivalent cysteine to
substrate selectivity of MKPs is, in part, due to their
Key words: MAPK dephosphorylation; MKP phosphatase domain;
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Figure 1. Functional Domains of MKPs
(A) Domain organization of PAC-1 and MKP-3. N-terminal kinase binding domain, blue; C-terminal phosphatase domain, orange. Numerals
indicate domain boundaries based on the structural analysis. The functionally important sequences, including the kinase interaction motif,
the general acid loop, and the phosphatase active site loop, are highlighted with shaded boxes.
(B) Sequence alignment of the phosphatase domains. Absolutely conserved residues, red; highly conserved residues, blue. Sequence numbers
are indicated along the protein sequences. Secondary structures of the PAC-1 phosphatase domain are shown as colored rectangles (
helices) and arrows ( strands). Asterisks highlight the PAC-1 catalytic residues, i.e., D226, C257, and R263. Note that the enzymatic nucleophile
C257 of PAC-1 was changed to serine in the NMR study.
(C) GST pull-down study of PAC-1 and ERK2 interaction. Western blot with anti-GST antibodies shows binding of the GST fusion PAC-1 and
MKP3 proteins immobilized on the GST Sepharose beads (left panel). The middle panel depicts Western blot with anti-hisidtine tag antibodies,
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serine in protein tyrosine phosphatases has been shown (see below); stability of the protein was dramatically
increased in the presence of phosphate. These promis-to abrogate catalytic activity, but to retain substrate
recognition [28, 29], making it feasible for studying the ing results prompted us to determine the three-dimen-
sional structure of the phosphatase domain of PAC-1enzyme-substrate complex. This mutation in PAC-1 did
not cause any significant structural perturbation of the (residues 170–314) in a 5 mM phosphate buffer of pH
6.5. The phosphatase domain, determined with a totalprotein, as judged by NMR spectral analysis. To investi-
gate the feasibility of structural determination of an en- of 2374 NMR-derived distance and dihedral angle re-
straints [30], adopts a compact tertiary structure (Figurezyme-substrate complex, we performed NMR binding of
the phosphatase domain with phosphorylated peptides 1B). An ensemble of the 20 lowest-energy NMR struc-
tures and a ribbon diagram of the average minimizedderived from the ERK2 activation loop (residues 175–
193, DHDHTGFLpTEpYVATRWYRA). Surprisingly, both structure are depicted in Figures 2A and 2B. Excluding
a flexible 4–5 loop (residues 288–304), the NMR struc-NMR titration and intermolecular NOE experiments re-
vealed that the PAC-1 protein, composed of residues tures are well defined (Table 1).
170–314 or 127–314, did not form a stable complex with
either mono- or bis-phosphorylated ERK2 peptide. Spe- Structure of the Phosphatase Domain
The PAC-1 phosphatase domain contains an / struc-cifically, at 1:1 protein-peptide molar ratio, backbone
amide resonances of the protein in the 15N-HSQC spec- ture, consisting of a central six-stranded mixed  sheet
with a folding topology of1x,2x,2x,1x,2x thattrum showed negligible chemical shift perturbations, as
compared to the free form spectrum. Even when the is sandwiched by four  helices on one side and one
helix on the other (Figure 2B). The location of the enzymepeptide concentration was increased to a 1:10 protein-
peptide molar ratio (with 5 mM peptide), resonance active site is marked by the conserved phosphatase
signature sequence HCXXXXXR (residues 256–263) inperturbation of the protein was still very small and lim-
ited to a few residues (data not shown). NMR titra- the 6–3 loop (Figure 2C), where C257 is the enzymatic
nucleophile and R263 coordinates with the phosphatetion with a shorter ERK2 peptide (residues 177–189,
DHTGFLpTEpYVATR), in its mono- or bis-phosphory- group on phosphotyrosine or phosphothreonine. The
conserved D226, which corresponds to D262 in MKP-3lated form, showed similarly weak interactions with the
phosphatase domain. As NMR can detect weak, but and is believed to serve as a general acid by donating
a proton to phenolic or hydroxyl oxygen of the leavingspecific, protein-ligand interactions (Kd of M to mM),
these observations may be explained by two reasons: group of a substrate [31], resides in the so-called general
acid loop connecting 5 and 2 (Figure 2C).(1) the synthetic ERK2 peptide loses its geometric con-
formation adopted in the ERK2 protein that is required While the overall fold of the PAC-1 phosphatase do-
main structure is very similar to the structure of thefor enzyme-substrate binding, and (2) the active site
conformation of the phosphatase domain alone is al- MKP-3 phosphatase domain determined by X-ray crys-
tallography [27], differences of structural elements dotered as compared with the full-length PAC-1 and, thus,
not suited for stable enzyme-substrate complex for- exist between the two structures (Figures 2C and 2D).
For instance, 1, which is packed antiparallel to themation.
To test these possibilities, we performed an in vitro central strands on one side of the  sheet in PAC-1, is
one turn shorter in the crystal structure. Conversely, 4,binding assay using recombinant and purified GST fu-
sion PAC-1 and dual-phosporylated ERK2 proteins. As which forms three turns in the crystal structure, has only
two turns in the NMR structure, the latter of which isshown in Figure 1C, the phosphatase domain of PAC-1
(residues 170–314 or 127–314) exhibited no detectable followed by a long and flexible 4–5 loop. The relative
orientation of 5 with respect to the active site helix 3binding to ERK2 (lanes 5 and 6), whereas binding of the
full-length PAC-1 to ERK2 was comparable to that of is also different—it is 30 in the MKP-3 structure and
75 in the PAC-1 structure. Another notable structuralMKP-3 (lanes 4 and 7). These results substantiate our
NMR titration results and argue that the active site con- difference is the location of the 5–2 loop, which con-
tains the catalytically important residue D226. In theformation of the phosphatase domain of PAC-1, in the
absence of the kinase binding domain, is not optimal crystal structure of MKP-3, the equivalent D262 is disen-
gaged from the other catalytic residues by over 10 A˚.for substrate recognition and that the full-length PAC-1-
ERK2 association results from the phosphatase domain On the basis of this distinct structural feature, it was
suggested that a major conformational rearrangementbinding to the dual-phosphorylation site in ERK2 and/or
the kinase binding domain interaction with ERK2 in re- would have to take place in order to bring the catalytic
residues together for full enzymatic activity in catalysisgions other than the phosphorylation site.
While the phosphatase domain does not bind to the [27]. However, in PAC-1, the corresponding loop con-
taining D226 appears closer to the phosphatase signa-ERK2 peptide, it interacts with phosphate, which is a
competitive inhibitor for the enzyme. Interestingly, the ture sequence (Figure 2C). This striking structural differ-
ence could be, in part, due to differences in the bufferprotein gives rise to excellent NMR spectra in a buffer
containing low, but not high, phosphate concentration conditions in the two structural studies (see below).
showing the relative amount of the ERK2 protein bound to PAC-1 and MKP3 proteins on the GST column in each binding experiment. The
right panels are Western blots with anti-ERK1/2 or anti-ACTIVE ERK1/2 antibodies (Promega), demonstrating that the recombinant ERK2
protein used in this study was dual phosphorylated on T183 and Y185 in the activation loop. PC12 cell extracts with or without treatment of
nerve growth factor (NGF) (lanes 10 and 11) (Promega) were used as positive or negative controls, respectively.
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Figure 2. NMR Structure of the Phosphatase Domain of PAC-1
(A) Stereo view of the backbone atoms (N, C, and C’) of 20 superimposed NMR-derived structures of the PAC-1 phosphatase domain (residues
170–314). Four N-terminal residues that are structurally disordered are omitted for clarity. The secondary-structural elements of  helices and
 strands are colored in green and orange, respectively.
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Table 1. NMR Structural Statistics of the PAC-1 Phosphatase Domain
Total experimental restraints 2374
Total NOE distance restraintsa 2138
Ambiguous 173
Unambiguous 1965
Intraresidue (i 	 j) 768 (39.1%)
Sequential (|i  j| 	 1) 444 (22.6%)
Medium (2 
 |i  j| 
 4) 339 (17.3%)
Long range (|i  j|  4) 414 (21.1%)
Hydrogen bond restraints 110
Dihedral angle restraints 126
Final energies (kcal · mol1)b
ETotal 213.1  16.2
ENOE 20.2  6.1
EDihedral 0.2  0.1
EL–J 644.2  20.1
Ramachandran Plot (%) Full Moleculec Secondary Structured
Most-favorable region 71.3  2.5 91.9  3.0
Additionally allowed region 21.2  2.6 8.1  1.0
Generously allowed region 6.2  2.0 0.0  0.0
Disallowed region 1.4  1.1 0.0  0.0
Rmsd’s of Atomic Coordinates (A˚)
Backbone 0.75  0.09 0.51  0.08
Heavy atoms 1.27  0.10 0.99  0.08
a Of the 2138 total NOE-derived distance restraints, 881 were obtained with the ARIA program, and 173 of those are classified as ambiguous
NOEs. The latter resonance signals in the spectra match with more than one proton atom in both the chemical shift assignment and the final
NMR structures.
b Based upon the 20 lowest-energy minimized structures. The Lennard-Jones potential was not used during any refinement stage. None of
these final structures exhibit NOE-derived distance restraint violations greater than 0.5 A˚ or dihedral angle restraint violations greater than 5.
c Residues 173–287 and 305–312.
d Residues 173–176, 180–183, 188–197, 201–204, 211–213, 218–221, 237–248, 253–256, 265–274, 280–287, and 305–312.
Analysis of surface electrostatic potential shows that substrate analogs. Remarkably, addition of phosphate
the enzyme active site is located at one end of a surface- causes extensive portions of the enzyme (more than just
exposed channel lined by the 4–5 loop on one side the active site region) to exhibit major backbone amide
and the 2–1 and 6–3 loops as well as the interdo- resonance changes (Figure 3A), implicating a global
main linker sequence (N-terminal to 1) on the other structural alteration. This phosphate-dependent global
side (Figures 2C and 2F). In addition to R263 at the structural perturbation is possibly due to phosphate
active site, a group of positively charged residues, K288, binding to more than just the active site and may explain
R290, and R291, are clustered at the other end of this the marked differences of the structural elements, i.e.,
crevice, suggesting another binding site for the phos- the 5–2 loop, between the NMR structure of PAC-1
phorylated residue(s) in ERK2. The back surface of the and the crystal structure of MKP-3, which were deter-
enzyme, opposite to the active site (the front surface), mined in a 5 mM phosphate buffer of pH 6.5 and in a
is also distinctively polarized (Figure 2E). Surface- 100 mM Tris buffer of pH 8.2 containing 2.5 M NaCl,
exposed residues R218, K247, R252, R276, R277, and respectively.
R279 form a continuous and positively charged patch Unexpectedly, the major perturbed residues upon ad-
that is surrounded by a strip of negatively charged resi- dition of p-nitro-phenyl phosphate (pNPP), which mim-
dues, including E175, D190, E231, D281, E282, D285, ics phosphotyrosine, are clustered mostly in 3, 4, and
and E308. This distinctive structural feature suggests the 2–1 loop instead of at the active site between 6
that this is a potential site for protein-protein interaction. and 3 (Figure 3B). This result argues that the PAC-1
active site, when bound to phosphate, is in a closed
state (see below) and that the positively charged cavitySubstrate Binding
To characterize the active site, we conducted NMR titra- comprising K288, R290, and R291 is a site (other than
the active site R263) that binds to one phosphorylatedtion of the phosphatase domain with small molecular
(B) Ribbon depiction of the averaged minimized NMR structure of the phosphatase domain. Orientation of the structure and color-coding
scheme for  helices and  strands in (A) and (B) are same.
(C) Ribbon diagram of the PAC-1 structure in a view opposite to that shown in (B), illustrating the structural elements of the enzymatic active
site (orange). Side chains of the active site residues D226, C257S, and R263 are color-coded by atom type.
(D) Ribbon diagram of the crystal structure of the phosphatase domain of MKP-3, prepared with the structure coordinates obtained from the
Protein Data Bank (ID code 1MKP). The orientation and color-coding for MKP-3 are similar to those used for PAC-1 in (C).
(E and F) Electrostatic potential surface representation of the PAC-1 phosphatase domain. Negatively charged residues, red; positively charged
residues, blue. The orientation of the molecular surface representation in (E) and (F) is similar to that in (B) and (C), respectively. (A) was
prepared by InsightII, (B), (C), and (D) were prepared with Ribbons [41], and (E) and (F) were prepared by GRASP [42].
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Figure 3. Molecular Interactions of the PAC-1 Phosphatase Domain
(A, B, and C) Ribbon diagrams of the phosphatase domain (residues 170–314), highlighting the residues that exhibited major resonance
changes upon addition of phosphate (20 mM), pNPP (20 mM), or phosphorylated threonine (10 mM), respectively, to the protein sample in a
20 mM HEPES buffer of pH 7.2 containing 5 mM DTT-d6 and 500 mM NDSB-201 (nondetergent sulfobetaines). NDSB-201, which does not
affect the structure of the PAC-1 phosphatase domain, was used to enhance stability of the protein in the free form (without phosphate).
(D) Ribbon diagram of the PAC-1 phosphatase domain, illustrating the residues that underwent significant resonance changes in the NMR
spectra upon addition of the MKP-3 kinase binding domain (residues 1–154).
(E) Ribbon diagram of the PAC-1 protein, showing the effect of the interdomain linker sequence (residues 131–169) on chemical shifts of the
phosphatase domain (residues 170–314), based on the spectral comparison between the PAC-1 proteins consisting of residues 170–314 and
131–314. The protein residues are categorized into three groups according to the extent of chemical shift perturbation and are color-coded:
red, large resonance shifts (0.20 ppm); gold, medium changes (0.20–0.10 ppm); blue, small or no changes (0.10 ppm). The results reflect
the sum of the chemical shift changes of the backbone amide 1H and 15N resonances, as observed in the 15N-HSQC spectra.
residue in EKR2. The latter seems to agree with the condition, showed little or negligible spectral changes
upon addition of phosphorylated tyrosine (data notsurface electrostatic potential of the molecule (Figure
2F). Since phosphotyrosine of the dual-phosphorylated shown). It is important to note that the single-phosphor-
ylated amino acids used in the NMR titration with theERK2 has been shown to be dephosphorylated first [25],
it is conceivable that this newly discovered phosphate phosphatase domain were not ideal because of their
positively charged amino, and negatively charged car-binding site is for phosphothreonine recognition. These
results suggest direct and possibly simultaneous recog- boxyl, groups, which could interfere with enzyme and
substrate recognition. Another possibility is that, evennition of both phosphotyrosine and phosphothreonine
at the active site of PAC-1. when bound to phosphate, the active site of PAC-1 is
still structurally disengaged for coordinating a substrateWhy does pNPP not bind to the enzyme active site?
One possibility is that, when bound to phosphate, the for catalysis. A full substrate engagement would require
conformational rearrangement of the enzyme active siteactive site is locked in a closed state, thus preventing
it from binding to pNPP (KD of 5 mM, as estimated by through interactions between the two functional do-
mains of PAC-1.NMR titration). This explanation is consistent with the
observations that (1) the 5–2 loop is closer to the
active site in the NMR structure (a closed state) than in Interdomain Interactions
To address how the N-terminal kinase binding domainthe crystal structure (an apo state), (2) residues per-
turbed by phosphorylated threonine titration are in re- affects the active site conformation of the C-terminal
phosphatase domain, we examined interdomain inter-gions similar to those perturbed by pNPP binding (Fig-
ures 3B and 3C), and (3) the enzyme, under the same actions. Because of the very low protein expression
Structure of the Phosphatase Domain of MKP PAC-1
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Figure 4. Protein Conformational Dynamics of the MKP Domains
Two-dimensional 15N-HSQC spectra of the PAC-1 phosphatase domain (residues 170–314) collected in different conditions of (A) a 5 mM
sodium phosphate buffer of pH 6.5 containing 5 mM DTT-d10 or (B) a 100 mM phosphate buffer of pH 6.5 containing 5 mM DTT-d10.
(C) The PAC-1 phosphatase domain in the same buffer condition as that described in (B) plus a nonlabeled N-terminal kinse binding domain
from MKP-3 (residues 1–154) (right panel). 15N-HSQC spectrum of the MKP-3 N-terminal kinase binding domain (residues 1–154) collected in
(D) a 100 mM sodium phosphate buffer of pH 6.5 containing 5 mM DTT-d10 and 200 mM urea or (E) in a 5 mM phosphate buffer of pH 6.5
containing 5 mM DTT-d10 and 200 mM urea.
(F) The MKP-3 protein in the same buffer condition as that described in (D) plus a nonlabeled C-terminal phosphatase domain from PAC-1
(residues 170–314). Note that the relatively low amount of urea, which showed no significant effect on the protein structure, as supported by
NMR spectra, was used to stabilize the protein during NMR data collection.
level of the PAC-1 kinase binding domain, but its high The two MKP domains, although composed of com-
pact tertiary structures, are highly dynamic in solution.sequence identity to that of MKP-3 (51% identity and
additional 19% similarity), we used the N-terminal do- For instance, the phosphatase domain of PAC-1 is in a
stable conformation in a 5 mM sodium phosphate buffermain from MKP-3 (residues 1–154) and the C-terminal
domain from PAC-1 in the NMR binding study. The key of pH 6.5, as illustrated by its excellent 15N-HSQC spec-
trum (uniform and narrow line width of protein amidecontact points between these two functional domains,
as revealed from the NMR titration, are localized on one resonance peaks) (Figure 4A). However, the protein res-
onances become significantly broadened when theside of the phosphatase domain, away from the active
site, involving 4, 2, and 5 (Figure 3D). To determine phosphate concentration is increased to 100 mM (Figure
4B), indicating that the protein exists in multiple confor-the role of the interdomain linker sequence, we further
compared NMR spectra of PAC-1 consisting of residues mations that undergo an intermediate to fast exchange
on the NMR timescale. Likewise, conformation of the131–314 and 170–314. Binding of the linker sequence
appears to occur on the back side of the phosphatase kinase binding domain of MKP-3 is also dependent on
buffer ionic strength—it is more stable in a high-ionicdomain, almost directly behind the active site, involving
4, 5, 1, and 2 (Figure 3E). Residues in the phospha- strength buffer than in a low-ionic strength buffer (Fig-
ures 4D and 4E). This buffer ionic strength dependencetase signature sequence of the 6-3 loop and in 3 are
also perturbed. These results confirm that the domain- of conformational heterogeneity is reversible and was
significantly diminished when the two domains weredomain interactions, via their linker sequence, may di-
rectly affect the active site geometry of the MKP. brought together (Figures 4C and 4F). Taken together,
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stitutively active MEK1 R4F in E. coli BL21(DE3) cells and purifiedthese results argue that interdomain interactions be-
with procedures previously reported [32, 33].tween the two MKP functional domains are coupled to
their functions.
NMR Spectroscopy
All NMR spectra were acquired at 25C on a 600 MHz or 500 MHz
Biological Implications Bruker DRX NMR spectrometer. 1H, 13C, and 15N resonances of the
protein were assigned with standard deuterium-decoupled triple-
resonance spectra of HNCA, HN(CO)CA, HN(CA)CB, HN(COCA)CB,Dual-specific MKPs inactivate MAPKs that control mito-
and (H)C(CO)NH-TOCSY [30, 34], recorded on a uniformlygenic signal transduction in all eukaryotic organisms
15N/13C-labeled and fractionally deuterated protein. The side chain[1–3, 6, 7]. MKPs that consist of an N-terminal kinase
assignments were completed with 3D HCCH-TOCSY [35] data col-
binding domain and a C-terminal phosphatase domain lected from a uniformly 15N/13C-labeled protein. NOE-derived dis-
exhibit very low phosphatase activity in the absence of tance restraints were obtained from 15N- or 13C-edited 3D NOESY
substrates [15–19]. MKP binding to a selective MAPK spectra [35]. φ angle restraints were determined from 3JHN,H cou-
pling constants measured in a 3D HNHA-J spectrum [35]. Slowlyresults in activation of the phosphatase activity in a
exchanging amide protons were identified from a series of 2Dsubstrate-induced activation mechanism [20, 24, 25],
15N-HSQC spectra recorded after the H2O buffer was changed torather than autoinhibition, commonly seen in other pro- 2H2O buffer. All NMR spectra were processed with NMRPipe [36]tein phosphatases [26]. Our new solution structure of and analyzed with NMRView [37].
the C-terminal phosphatase domain of PAC-1 and the
identification of its interaction sites for the N-terminal
Structure Calculationskinase binding domain and for phosphotyrosine and
Structures of the PAC-1 protein were calculated with a distancephosphothreonine in the activated ERK2 represented
geometry simulated-annealing protocol with X-PLOR [38]. Initial
here provide a key piece of knowledge toward full struc- structure calculations were done with manually assigned NOE-
tural realization of the mechanism of action underlying derived distance restraints. Hydrogen bond distance restraints were
MAPK-induced enzymatic activation of an MKP. In the added at the late stage of structure calculations for residues with
characteristic NOE patterns. The converged structures were thenabsence of the substrate, the N-terminal kinase binding
used for the iterative automated assignment of the NOE spectra bydomain of an MKP is associated with its C-terminal
ARIA [39], which integrates with X-PLOR for the structure refine-phosphatase domain via the interdomain linker se-
ment. The final structure calculations employed a total of 2138 NOE-
quence, and the enzyme exists in a low-activity state derived distance restraints obtained from the manual and ARIA-
because of disengagement of its active site residues. assisted assignments from the 15N- or 13C-edited NOE data. The
Alteration of the cooperative interdomain interactions NOE-derived restraints were categorized on the basis of the ob-
served NOE peak intensities. Additionally, 110 hydrogen bond dis-of an MKP resulting from its N-terminal domain binding
tance restraints for 55 hydrogen bonds and 126 φ and  angleto an MAPK allosterically triggers conformational re-
restraints, determined from the 3D HNHA-J experiment and TALOSarrangement of the phosphatase active site for specific
program [40], were also used in the calculations. For the final 20
recognition of the MAPK’s dual-phosphorylation se- lowest-energy NMR structures, no distance or torsional angle re-
quence, leading to enzymatic activation of the MKP to straint was violated by more than 0.5 A˚ or 5, respectively (Table 1).
a high-activity state that is essential for dephosphoryla-
tion and inactivation of the MAPK. This dynamic cou-
Protein Bindingpling of MAPK inactivation to MAPK substrate-induced
Protein-protein and protein-ligand binding studies were performed
activation of an MKP provides a tightly controlled regula- by recording a series of 2D 1H-15N HSQC spectra on the uniformly
tion that enables these two key enzymes to keep each 15N-labeled PAC-1 phosphatase domain (0.2 mM) with and without
other in check and thereby guarantees the fidelity of the MKP-3 N-terminal kinase binding domain (0.20–0.50 mM), phos-
phate, p-nitrophenyl phosphate, or ERK2 peptides. The protein sam-intracellular signal transduction.
ples were prepared in the same aqueous buffer containing 5–100
mM sodium phosphate and 5 mM perdeuterated DTT-d10 at pH 6.5.
Experimental Procedures The GST fusion proteins (5 M) of PAC-1 C257S mutant or the full-
length MKP-3 C299S mutant bound to the glutathione Sepharose
Sample Preparation beads (Amersham Biosciences) were incubated with the purified,
cDNA sequences encoding the phosphatase domain of PAC-1 con- activated, and dual-phosphorylated ERK2 (20 M) in 50 mM sodium
sisting of residues 131–314 or 170–314 were subcloned into a phosphate buffer of pH 6.5 containing 150 mM NaCl and 1 mM DTT
pET15b expression vector (Novagen), which produces the recombi- at 25C for 30 min and then at 4C for 2 hr. The glutathione Sepharose
nant protein with a hexahistidine (His6) sequence at the N terminus. beads (10 l) were washed extensively with the phosphate buffer.
The enzymatic nucleophile C257 in the phosphatase domain was Proteins eluted from the Sepharose beads were separated by SDS-
mutated to serine for the NMR structural study. The proteins were PAGE and visualized by Western blotting with anti-GST antibody
overexpressed in Escherichia coli BL21(DE3) cells. Uniformly 15N- (Pierce) or anti-histidine tag antibody (Amersham) and alkaline phos-
and 15N/13C-labeled proteins were prepared by growing bacteria at phatase-conjugated donkey anti-mouse IgG (Promega). The dual-
37C in an M9 minimal medium containing 15NH4Cl with or without phosphorylation state of ERK2 was confirmed by Western blotting
13C6-glucose in H2O or 75% 2H2O. Protein induction was conducted with anti-pT183 ERK1/2, anti-ACTIVE (pT183EpY185) ERK1/2, and anti-
at 25C for about 4 hr with 0.3 mM IPTG (isopropylthio--D-galacto- pY antibodies (Promega).
side). The phosphatase domain was purified by affinity chromatog-
raphy on a Hi-Trap nickel column (Pharmacia) and then by cleavage
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